Atracurium besylate
Atracurium besylate (51W89) is a short-acting, non-depolarizing neuromuscular blocker. Its favorable profile includes minimal cardiovascular impact and elimination independent of renal function, making it a valuable pharmacological tool for research in anesthesia, neuromuscular physiology, and in vivo surgical models.
Product Specifications
CAS Number
64228-81-5
Product Name Alternative
51W89, anticancer, Atracurium besylate, BW-33A, bronchoconstriction, GSC cells, Inhibitor, inhibit, inflammatory, nAChR, neuromuscular blockade, Nicotinic acetylcholine receptors, Tracrium
Field of Research
Neuroscience, Pharmacology & Drug Discovery
Purity
98.00% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (1.61 mM) ; DMSO:60 mg/mL (48.25 mM)
Smiles
[O-]S (=O) (=O) c1ccccc1.COc1ccc (CC2c3cc (OC) c (OC) cc3CC[N+]2 (C) CCC (=O) OCCCCCOC (=O) CC[N+]2 (C) CCc3cc (OC) c (OC) cc3C2Cc2ccc (OC) c (OC) c2) cc1OC.[O-]S (=O) (=O) c1ccccc1
Molecular Formula
C65H82N2O18S2
Molecular Weight
1243.49
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MR221808L4V 200 µL
Serpinb10 (NM_198028) Mouse Tagged ORF Clone Lentiviral Particle
Sign In for Pricing
View Details 